Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Quoting GF Tweet minutes ago~ $ENZC - I am pleasantly surprised our Company now has a "Genetics and Molecular Biology Data Science TEAM". ?? Very subtle yet significant changes that will be forthcoming. This alone could've been a PR on its own talking about our new division. Incredible ?? https://t.co/BohjpcK97n
Here we go Whale.
Let's get back up over .16
ENZC Has HIV CURE!
Volume precedes price$$$
.26 on ask
The Genscript connection:
#BiGNews $ENZC Announces The Discovery Of Seven Newly Identified Conserved Target Sites On The #HIVvirus. @GenScript is honored to be the partner for the production of the primary anti-#HIV #monoclonalantibodies. ??????
https://t.co/yJy8nRrntR
Hold on to your hats folks.
Vamoos
I checked it to day on OTC. Hope that helps.
https://www.otcmarkets.com/
Note the one syllable word "HAS", not will, or maybe-
Enzolytics has a License Agreement for US Patent 7479538. The claim is Irreversibly-inactivated Pepsinogen Fragments for Modulating Immune Function.
You can find this on the company web site, Enzolytics.com
Ewll owns PHZIO according to OTC web site:
QUOTE, "eWellness Healthcare Corporation is the first physical therapy telehealth company to offer real-time distance monitored treatments. Our business model is to have large-scale employers use our PHZIO system as a fully PT monitored corporate wellness program."
Note- "OUR PHZIO system"
Interesting last paragraphof this article:
Data sets up 2021 filings for Gilead’s twice-a-year HIV drug lenacapavir
November 19, 2020
. . . .
"Expanding the use of lenacapavir into the broader population could be complex however as Gilead will need to find another long-acting drug that can be partnered with it to reduce the risk of resistance to the capsid inhibitor."
Does this look like a vaccine product or a treatment?
Patience x Patients= Pennies
Agree with you and congratulations on you successful oil career. Wishing you the best .
$ENZC. GLTL(Good luck to longs)
Right. The 1st and 15th of each month. Monday is the 1st. Let's see what happens. GLTA
On the positive side all those shares are measly pocket change for a company like ATI. Telemed is rapidly emerging during the pandemic. The pandemic is changing how we live. Telemed looks like it will be the new norm even after the Covid era.
Last I checked, 3¢ is copper.
It has already merged. Stop sign is down. Charles Cotopia is CEO.
Info from OTC site:
Business Description Enzolytics, Inc. (the "Company" or "ENZC") is a drug development company committed to the commercialization of its proprietary proteins for the treatment of debilitating infectious diseases. The Company is committed to creating drugs for the better health of mankind. ENZC's flagship compound ITV-1 is a suspension of Inactivated Pepsin Fragment (IPF), which studies have shown is effective in the treatment of HIV. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system. IPF is a platform technology that can be used to facilitate a broad range of applications. It is free from major neurological, gastrointestinal and hematological side effects seen in the anti-retrovirals in use today. IPF has not shown to be subject to viral resistance and is cost effective.
ENZOLYTICS INC.
2000 North Central Expressway
Plano, TX 75074
Patients.
Bux, That's an awesome article helping to get the word out. Some here may not have seen it:
President Trump’s hospitalization for COVID-19 has shed the spotlight on the most important aspect in the treatment of the coronavirus – monoclonal antibodies. Dr. Anthony Fauci, the head of the National Institute of Allergy and Infectious Diseases (NIAID), is focused on looking at antivirals that have treated other infectious diseases like HIV to treat COVID-19. Two companies at the forefront of HIV therapeutics are ENZC and BioClonetics, which are set to merge.
Enzolytics' flagship compound ITV-1 (Immune Therapeutic Vaccine-1) is a suspension of Inactivated Pepsin Fraction (IPF), which studies have shown is effective in the treatment of HIV/AIDS. IPF is the active drug substance of ITV-1 and is a purified extract of porcine pepsin. ITV-1 has been shown to modulate the immune system.
$ENZC It's actually a blessing that no PR was released this week. Nobody would have paid attention, and the stock would have underperformed.
It doesn't really matter if we are 18 cents right now or 25 cents. Next week we should get some important news. Could be funding or collaborations as Charles said are forthcoming. Next leg up .30s.
You got it bud.
$ENZC They keep updating website they just updated the Leadership tab and added a description of Cotropia's experience. Something major is coming.
I may have jumped the gun. Took tweets for the Gospel. Sorry
Enzolitics Web site updated. WHO info. on HIV.
Lock your shares.
Set your sell orders to prevent the shorts from borrowing your precious shares. The big boys are invading the OTC as we speak.
Will this go to 3¢???
Just getting back in today. I was in years ago and sold due to poor management. Is the "dingy dilution dame" out of the picture now???
I see there's a marketing team now. That's what was needed all along , duh. This is about to go up fast IMHO.
Grab some Mabs man.
Slap the ask.
20¢ or $20 Wam??
Probably WORD is spreading at Warp Speed on A&M campus.
Blue skies from 20¢!!$$$$
The world needs ENZC technology ASAP
Jan 25 (Reuters) - Drugmaker Merck & Co on Monday said it will end development of its two COVID-19 vaccines, and will focus pandemic research on treatments, with initial efficacy data on an experimental oral antiviral expected by the end of March.
Interesting article about Moderna's most recent pipeline. Hmmm
". . .Moderna recently rolled out their new programs targeting the seasonal flu, targeting HIV. . ."
I'm so glad we have an abundance of gray matter here. We are blessed beyond measure.